HMOX1 and chronic obstructive pulmonary disease: In line with this, therapeutic manipulation to induce the levels of HO-1 or its enzymatic products has been suggested as a potential clinical intervention to protect normal lung architecture and limit disease progression during pulmonary diseases including chronic obstructive pulmonary disease, cystic fibrosis and asthma [15,16].